Prostate-specific antigen

Prostate cancer is considered as the most commonly diagnosed cancer in men, in the U. S and most cases of prostate cancer have a good prognosis. Some of these cases can be aggressive and the death-rate is assessed to be 2.8%. The Prostate-specific antigen (PSA) test is used for screening for prostate cancer, to aid early detection and treatment. Prostate-specific antigen (PSA) test Prostate-specific antigen (PSA) is a protein produced by the prostate gland, found in the blood. Blood sample

Prostate Cancer Eng 101 Andrell Nash Fortis College Abstract Prostate Cancer is a disease in which there is an uncontrolled growth of cells that lines the ducts of the prostate gland. The abnormal cells can spread throughout the prostate and nearby organs, such as the seminal vesicles. If not caught early they can spread (metastasized) to other organs of the body through the lymph or blood stream. (“...Treatment...” 13) Prostate Cancer can be like a silent killer. Some may show signs and symptoms

detect or identify the presence of a specific cancer before the individual displays any symptoms of cancer. Early detection of a cancer through screening can save the life of a person who may have died without screening detection. Early detection of cancer can also provide a less costly and more effective treatment than if the cancer progresses requiring more advanced or drastic treatment. Screenings tests for the more common cancers such as breast, colon, prostate or cervical can be non-invasive or

detect or identify the presence of a specific cancer before the individual displays any symptoms of cancer. Early detection of a cancer through screening can save the life of a person who may have died without screening detection. Early detection of cancer can also provide a less costly and more effective treatment than if the cancer progresses requiring more advanced or drastic treatment. Screenings tests for the more common cancers such as breast, colon, prostate or cervical can be non-invasive or

Controversial PSA test In 1994, prostate-specific antigen (PSA) was officially approved for PCa screening by the FDA, and 4.0 ng/ml was set as the upper limit of normal range. Following its prevalent use, PSA became the most frequent method of detecting PCa and has resulted in a considerable stage migration. However, considerable controversy remains about PSA screening, due to questions regarding survival benefit, cost effectiveness, and clinical factors such as the optimal age and total PSA at which

be really difficult and no one wants any sickness or diagnosed with such a disease like cancer. Prostate Cancer is a known cancer that happen to men only and a lot of men in the U.S had it. The part that happens to male’s reproductive system and it is a gland found in the most private area of a men. Moreover, it is located in front of the rectum and under the bladder where it grows slowly. First, prostate cancer really affect men who diagnosed with it and we need to understand it first to be able to

Prostate Cancer Screening: An Analysis The paper Prostate Cancer Screening is written as an analysis of the controversy on the use of screening for prostate cancer. The paper itself is written between doctors Elie Mulhem, Nikolaus Fulbright, and Norah Duncan. The analysis, while likely directed to those in the medical field, is tailored to be easily understood by laypeople. While the paper itself is a somewhat brief, surface level analysis of the situation, it does support the notion that prostate

Immunotherapy of virus-associated cancers can be directed against viral-antigens vital for viral replication or growth. The human papillomavirus (HPV) E6 and E7 proteins interfere with normal cell-cycle regulation and are required for the viral life cycle. Examples of tumer antigen are Human Chorionic Gonadotropin (HCG): A glycoprotein hormone produced during pregnancy. Some cancerous tumors produce this hormone; therefore

Prostate cancer is the most common type of cancer in American men after skin cancer. There are many risk factors that increase the disease such as age, being the far most important risk factor, along with race, family history and diet (ASCO, 2015). The prostate is a walnut shaped gland of the male reproductive system that functions to create part of the semen, which is fluid in which sperm swim in when ejaculation occurs. It is located inferior to the bladder, anterior to the rectum, surrounding

Prostate is an exocrine gland of the male reproductive system, and exists directly under the bladder, in front of the rectum. Prostate cancer is most common cancer among men (older than 65 years) after skin cancer. But it can be treated successfully. Some are slow growing and some are relatively fast growing. They can travel through blood vessels to reach other parts of the body and attach to the tissues of that part to grow and form new tumors and damage that tissue. Growths in prostate can be